Court approves settlement over tainted injections

A bankruptcy judge has approved a $100 million settlement with the New England Compounding Center over the tainted injections that led to the deaths of 64 people and led to the infection of 751 patients with fungal meningitis.

The settlement includes resolution of claims against UniFirst and Liberty Industries. 

NECC partners Barry Cadden, Lisa Cadden, Carla Conigliaro and Greg Conigliaro will pay $47.5 million into the settlement fund.

Local attorneys Foley & Small are representing 90 patients or their survivors who received the tainted injections of methylprednisolone acetate.

The distributions will be in two parts-an initial primary distribution where the bulk of settlement funds will be distributed and a second later distribution that will occur after any claim appeals are resolved., according to a press release from Foley & Small.